SCHEMBL28152287

SCHEMBL28152287

COc1ccc(S(=O)(=O)NCCNc2cc(-c3cc(C)cc(C)c3)nc(N)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.46
▸ PKM P14618 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ MAPK14 Q16539 2/20 0.45
▸ HRH4 Q9H3N8 2/20 0.44
▸ BRAF P15056 3/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ RAF1 P04049 2/20 0.43
▸ PTGDR Q13258 2/20 0.43
▸ POLB P06746 1/20 0.41
▸ GABRG2 P18507 1/20 0.41
▸ GABRB3 P28472 1/20 0.41
▸ GABRA3 P34903 1/20 0.41
▸ FFAR4 Q5NUL3 1/20 0.41
▸ MAPK8 P45983 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28267602 0.89 HRH4 (0.47) ALDH1A1HRH4BRAFSMN1; SMN2
SCHEMBL28151179 0.84 HRH4 (0.51) MAPTHRH4SMN1; SMN2PTGDRPOLB
SCHEMBL28265781 0.82 ALDH1A1 (0.46) ALDH1A1MAPTHRH4SMN1; SMN2MAPK8
SCHEMBL28265753 0.82 TLR8 (0.46) ALDH1A1HRH4SMN1; SMN2
SCHEMBL15757787 0.82 NUDT1 (0.51) ALDH1A1PKMLMNAMAPTMAPK14
SCHEMBL28265690 0.82 MAPT (0.45) ALDH1A1PKMLMNAMAPTMAPK14
SCHEMBL28267598 0.81 TLR8 (0.55) ALDH1A1PKMLMNAMAPTMAPK14
SCHEMBL28265648 0.81 HRH4 (0.46) ALDH1A1MAPTMAPK14HRH4BRAF
SCHEMBL28267214 0.81 PTGDR (0.57) PTGDR
SCHEMBL28151149 0.78 HRH4 (0.64) HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105143206-B Pyrimidine -2,4- diamine derivative for treating cancer 托马斯·黑勒戴药物研究基金会 2019-01-15 — — CN claimed
CN-106794181-A MTH1 inhibitors for the treatment of inflammatory and autoimmune conditions 托马斯·黑勒戴药物研究基金会 2017-05-31 — — CN disclosed
Send feedback